口腔外科領域の各種感染症に対するsulbactam/cefoperazone (SBT/CPZ, スルペラゾン®) の臨床成績

概要

論文の詳細を見る
Clinical evaluations of Sulbactam Cefoperazone (SBT/CPZ, Sulpemzome®) in various infections in the field of oral surgery were carried out.Sulbactam/Ceforperazone was administered to 51 patients with various infections. Sulbactam/Cefoperazone wasadministered by intravenous injection at a daily dose of 2 g (1 g × 2 times). Cases consistedof31 with maxillary ostitis, 3 phlegmone of the floor of the mouth, 4 pericoronitis, 2odontgenic maxillary sinuitis, 4 buccal abscess, 3 infection of post operative maxillary cyst, 1parotitis, 1 submaxillary limphadenitis and 2 peritonsillitis. The clinical effects obtained insubjective judgement were exellent in 25 cases, good in 22, fair in 4 and poor in none. The clinical effects obtained in judgement by point were excellent in 14 cases, good in 33 and poor in 4.The effective rate of which was 92.2%, the same as the former. As for side effects, stomatic discomfort appeared in one case. In the laboratory examination, elevation of s-GOT was observed in A patient, andelevation of BUN was observed in another patient. The results indicated theusefullness of Sulbactam/Cefoperazone in the treatment of various infections in the field of oralsurgery.